Skip to main content
. 2018 Mar 21;12:605–617. doi: 10.2147/DDDT.S130809

Figure 1.

Figure 1

Clinical trials of rucaparib in ovarian cancer.

Note: *Ongoing trials.

Abbreviations: iv, intravenously; HGOC, high-grade ovarian cancer; HRD, homologous recombination deficiency; g, germline; s, somatic; uk, unknown; mut, mutant; PK, pharmacokinetics.